Shruti Agrawal

Author PubWeight™ 92.71^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.	N Engl J Med	2012	52.99
2	Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.	N Engl J Med	2012	35.24
3	Phase I dose-escalation and pharmacokinetic study of dasatinib in patients with advanced solid tumors.	Clin Cancer Res	2009	1.63
4	Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study.	Cancer	2011	1.49
5	Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors.	Cancer	2010	1.22
6	Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects.	J Clin Pharmacol	2009	1.11
7	Di-(2-ethylhexyl)-phthalate affects lipid profiling in fetal rat brain upon maternal exposure.	Arch Toxicol	2006	1.08
8	Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium.	J Clin Oncol	2011	1.04
9	Blepharochalasis.	Indian J Dermatol Venereol Leprol	2009	0.96
10	Clinical profile of dasatinib in Asian and non-Asian patients with chronic myeloid leukemia.	Int J Hematol	2009	0.92
11	Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.	J Clin Oncol	2013	0.89
12	Outcome of children with pulmonary lymphangiectasis.	Pediatr Pulmonol	2009	0.88
13	Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies.	Invest New Drugs	2011	0.81
14	A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study.	J Pharm Biomed Anal	2011	0.77
15	Appearance and location of retinal haemorrhages in critically ill children.	Br J Ophthalmol	2013	0.75
16	Cefpodoxime: pharmacokinetics and therapeutic uses.	Indian J Pediatr	2003	0.75